| Katherine Chiu, RPH | |
|
18 South Finley Ave, Suite 16, Basking Ridge, NJ 07920 | |
| (908) 766-7920 | |
| Not Available |
| Full Name | Katherine Chiu |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 18 South Finley Ave, Basking Ridge, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689876047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI02803700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Chiu, RPH 52 Patriot Hill Dr, Basking Ridge, NJ 07920 Ph: (908) 470-2993 | Katherine Chiu, RPH 18 South Finley Ave, Suite 16, Basking Ridge, NJ 07920 Ph: (908) 766-7920 |
News Archive
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
New tools have confirmed high rates of misdiagnosis of patients with chronic disorders of consciousness, such as the vegetative state. An increasing number of patients' families wish to use these novel techniques for diagnosis, prognosis, and treatment.
"The Meda Group expects to achieve sales of about SEK 11,400 million and an EBITDA of about SEK 4,400 million."
NovaBay Pharmaceuticals, Inc. a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, delivered two poster presentations on its compounds at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Vancouver, Canada.
ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.
› Verified 8 days ago
Alla Gutkin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 544 Allen Rd, Basking Ridge, NJ 07920 Phone: 908-470-2745 Fax: 908-470-0251 | |
Dr. John Patrick Timoney, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3144 Fax: 908-542-3219 | |
Emily Yen Araneta, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 544 Allen Rd, Basking Ridge, NJ 07920 Phone: 908-470-2745 | |
Arielle Greenspan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Lyons Mall, Basking Ridge, NJ 07920 Phone: 908-766-7920 Fax: 908-766-1947 | |
Amy Desai, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Lyons Mall, Basking Ridge, NJ 07920 Phone: 908-766-7920 Fax: 908-766-1947 | |
Eugene Zeng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Lyons Mall, Basking Ridge, NJ 07920 Phone: 908-766-7920 | |
Ami Patel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 544 Allen Rd, Basking Ridge, NJ 07920 Phone: 908-470-2745 |